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Introduction
Cerebrospinal	 Fluid	 (CSF)	 is	 an	 ultra-filtrate	
of	plasma	that	is	produced	by	the	choroid	plexus	
within	the	ventricular	system	to	the	central	canal	
of	 the	 spinal	 cord.	 CSF	 has	multiple	 roles	 in	 the	
central	nervous	system,	such	as	physical	support,	
pressure	 modulation,	 metabolites,	 nutrients,	
neurotransmitters	 transport	 and	 maintains	 also	
the	ionic	balance	(Di	Terlizzi	and	Platt,	2009).
Changes	 in	 the	 central	 nervous	 system	 can	
cause	changes	in	the	functionality	and	composition	
of	the	CSF	to	a	greater	or	lesser	degree.	This	is	why	
CSF	 became	 an	 integral	 part	 of	 the	 neurological	
investigation.	 For	 veterinary	 practitioners	
information	about	the	CSF	can	lead	to	neurological	
disorders,	 such	as	 inflammatory,	degenerative	or	
neoplastic	 (De	 Lahunta,	 1977;	 Vandevelde	 and	
Spano,	1977).
To	obtain	CSF	from	a	patient,	there	are	specific	
collection	sites,	such	as	cerebellomedullary	cistern	
and	from	the	lumbar	subarachnoid	space.	Details	
of	 the	 CSF	 collection	 techniques	 were	 not	 the	
objective	of	 this	review	and	are	 found	elsewhere	
(Jamison	and	Lumsden,	1988).
After	 the	 collection,	 the	 cerebrospinal	 fluid	
analysis	should	be	done	within	30	minutes	for	an	
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Abstract: 
From	the	early	20th	century,	 the	cerebrospinal	 fluid	(CSF)	analysis	was	an	 invaluable	diagnostic	process	 in	
clinical	neurology	and	later	in	veterinary	neurology.	For	the	clinicians,	the	CSF	analysis	provides	reliable	information	
about	the	neurological	health	and	the	presence	of	a	disease.	
The	purpose	of	 this	 review	 is	 to	bring	 scientific	 evidence	and	 support	 for	 the	 current	 state	 regarding	 the	
clinical	relevance	of	cerebrospinal	fluid	analysis	in	veterinary	neurology.	The	utility	of	this	review	is	to	highlight	
the	canine	breed	specific	diseases	in	veterinary	neurology	and	the	role	of	CSF	analysis	for	the	diagnosis	of	CSF	
inflammatory	disorders.
The	analysis	of	cerebrospinal	fluid	represents	an	important	diagnostic	tool,	which	has	to	be	assessed	in	every	
neurological	 patient	 in	 order	 to	 obtain	 information	 about	 the	 central	 nervous	 system.	Moreover,	 we	 strongly	
encourage	to	step	forward	with	this	diagnostic	procedure	and	corroborate	with	the	diagnostic	imaging	results.
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accurate	cell	count	and	cytology	(Chrisman,	1992).	
The	CSF	white	blood	cell	(WBC)	count	is	one	major	
part	of	the	analysis.	Normal	values	are	considered	
5	cells/μL.
Elevated	CSF	WBC	count	is	called	pleocytosis	
and	usually,	 it	 is	associated	with	inflammation	of	
the	 central	 nervous	 system	 (CNS).	 CSF	 cytology	
is	 necessary	 at	 every	 CSF	 evaluation,	 even	 if	 the	
WBC	 is	 low	 (Christopher	 et al.,	 1988).	 Another	
parameter	routinely	evaluated	on	CSF	is	the	total	
protein.	Normal	protein	levels	may	be	10	to	25	mg/
dL	in	the	CSF,	compared	to	normal	serum	level	5	to	
7.5	g/dL	(Jamison	and	Lumsden,	1988).	Elevation	
of	CSF	protein	 level	may	appear	 in	diseases	 that	
alter	 the	 BBB,	 local	 necrosis,	 interruption	 of	
the	 CSF	 flow	 or	 intrathecal	 globulin	 production	
(Sorjonen,	1990).	
Inflammatory disorders affecting the 
canine CNS
Inflammatory	 diseases	 of	 the	 CNS	 in	
dogs	 with	 forebrain	 neurological	 signs	 are	
important	 diagnostic	 considerations.	 A	 variety	
of	 inflammatory	conditions	of	 the	CNS	can	cause	
CSF	 changes.	 Inflammatory	 conditions	 can	 be	
divided	into	infectious	etiology	(such	as	bacterial,	
canine	 distemper	 virus,	 rabies,	 cryptococcosis,	
toxoplasmosis,	and	neosporosis	infection)	and	non-
infectious.	Meningoencephalomyelitis	termed	also	
meningoencephalomyelitis	of	unknown	origin,	has	
several	 subtypes:	 steroid	 responsive	 meningitis	
-	 arteritis,	 eosinophilic	 meningoencephalitis,	
granulomatous	meningoencephalo-myelitis	(GME)	
and	necrotizing	encephalitis	 (with	two	subtypes:	
Necrotizing	 meningoencephalomyelitis	 (NME)	
and	 necrotizing	 leucoencephalitis)	 (Cornelis	
et al.,	 2019).	 All	 have	 a	 common	 pathological	
characteristic	 described,	 influx	 of	 leukocytes	
into	 the	 brain,	 spinal	 cord	 or	 meninges.	 In	 the	
inflammatory	 process	 more	 than	 one	 structure	
can	be	involved,	for	instance	inflammation	of	the	
brain	and	meninges	together	(William,	1998).	
A	 usual	 misconception	 among	 veterinarians	
is	 that	 dogs	 with	 inflammatory	 CNS	 disease	 are	
usually	 with	 systemic	 manifestations	 also	 but	
commonly	 have	 no	 extraneural	 signs.	 Moreover,	
the	neurological	 deficits	 are	not	 disease-specific,	
because	 the	 inflammatory	process	can	affect	any	
portion	 of	 the	 CNS	 and	 can	 develop	 a	 variety	 of	
neurological	signs	(Tipold,	1995).	A	retrospective	
study	on	diagnosis	of	inflammatory	and	infectious	
diseases	of	the	CNS	in	dogs	shows	that	generalized	
or	focal	seizures	are	common	findings	and	are	seen	
in	13%	of	dogs	with	inflammatory	disease	of	the	
CNS	(Tipold,	1995).	Other	clinical	signs	manifested	
in	 inflammatory	 disorders	 localized	 in	 the	 CNS	
are	 central	 vestibular	 dysfunction,	 hypermetria	
or	disorders	of	consciousness	(Nelson	and	Couto,	
2014).
A	 retrospective	 study	 of	 Radaelli	 and	 Platt	
(2002)	about	bacterial	meningoencephalomyelitis	
in	 dogs	 demonstrated	 that	 it	 is	 an	 uncommon	
disease,	but	should	be	considered	when	an	animal	
is	presented	with	CNS	signs,	acute	neck	pain,	and	
pyrexia.	Furthermore,	the	neurological	signs,	neck	
pain,	and	pyrexia	with	abnormal	complete	blood	
count	and	serum	chemistry	profiles	were	shown	
to	 be	 useful	 to	 indicate	 an	 infection	 localized	 in	
CNS.	 In	 the	 same	 study,	 CSF	was	 analyzed	 in	 14	
dogs	and	the	CSF	was	abnormal	in	93%	of	samples.	
All	of	them	had	abnormal	CSF	protein	level	(range:	
164–777.7	mg/dL;	mean:	337.0	mg/dL;	reference	
range:	 15.0–35.0	mg/dL)	 and	11	of	 13	dogs	had	
increased	WBC	cell	count	(range:	18–10,850	cell/
μL),	with	a	prevalence	of	neutrophils	in	9	of	the	13	
dogs,	monocytes	in	2	of	the	13	dogs,	lymphocytes	
and	eosinophils	in	1	of	13	dogs.	The	CSF	was	also	
cultured	in	8	of	14	dogs.	The	results	of	the	culture	
of	 CSF	 in	 8	 dogs	 were	 positive	 in	 only	 1	 (13%)	
sample	(Corynebacterium spp)	(Radaelli	and	Platt,	
2002).
Canine	 distemper	 virus	 has	 various	 neuro-
pathological	 presentations;	 under	 natural	 condi-
tion,	 acute	 to	 chronic	 demyelinating	 encephalo-
myelitis	 is	 the	 most	 widespread	 clinical	 forms.	
Neurological	manifestations	usually	begin	after	1	
to	3	weeks	after	recovery	from	the	initial	systemic	
illness	 and	 may	 involve	 disorientation,	 seizures	
and	 circling.	 Moreover,	 “chewing	 gum”	 seizures	
produced	 by	 polioencephalomalacia	 of	 temporal	
lobes	 are	 frequently	 described.	 Additional	
“distemper	chorea”	is	very	common	in	dogs	with	
distemper	 encephalomyelitis	 (Greene	 and	Appel,	
2006).
Related	to	cryptococcosis,	in	a	large	case	series	
from	195	patients	(dogs	and	cats)	thirty	percent	of	
the	dogs	had	CNS	and/or	disseminated	signs.	This	
study	shows	that	cats	are	five	times	more	prone	to	
develop	 cryptococcosis	 than	dogs	 (O’Brien	et al.,	
2004).
Protozoa	is	not	a	common	cause	of	neurological	
diseases	in	canine	(Thomas,	1998),	however,	Toxo-
DANCIU et al
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plasma gondii	 and	 Neospora caninum	 (Paixão	
and	 Santos,	 2004)	 are	 occasionally	 reported.	
Based	on	a	study,	many	animals	are	serologically	
positive	 for	 toxoplasmosis,	 although	 few	develop	
clinical	 manifestations	 of	 the	 disease	 (Dubey	
and	 Lappin,	 2012).	 However,	 studies	 shown	
that	 the	 most	 common	 clinical	 signs	 of	 CNS	 in	
toxoplasmosis	were	ataxia,	seizure,	tremor,	cranial	
nerve	disorders,	progressive	paresis	and	paralysis	
(Averill	and	De	Lahunta,	1971;	Nesbit	et al.,	1981;	
Suter	et al.,	1984;	Braund	et al.,	1988;	Davidson,	
2000).
In	 a	 recent	 report	 in	 which	 Neospora 
caninum	 and	 Erlichia canis	 co-infection	 with	
meningoencephalitis	 was	 described	 (Aroch	 et 
al.,	 2018),	 CSF	 obtained	 from	 cisterna	 magna	
showed	a	marked	pleocytosis,	the	total	nucleated	
cell	 count	was	 650	 cell/µL	 and	 increase	 protein	
concentration	was	 observed	 (791,3	mg/dL).	 CSF	
cytology	 showed	 a	mixed	 pleocytosis	 with	 44%,	
eosinophils,	 34%	 monocytes,	 14%	 neutrophils,	
6%	 lymphocytes	 and	 2%	 reactive	 macrophages	
(Aroch	 et al.,	 2018).	 CSF	 cytology	 may	 reveal	
bacteria	 or	 fungal	 elements,	 further	 CSF	 culture	
can	 solution	 the	 definitive	 diagnosis	 (Chrisman,	
1992).	 Meningoencephalomyelitis	 of	 unknown	
origin	(MUO)	enclose	the	idiopathic	CNS	diseases	
(Talarico	 and	 Schatzberg,	 2010).	 This	 group	 of	
diseases	 has	 a	 worldwide	 distribution	 and	 was	
reported	 for	 5%	 to	 25%	 of	 all	 CNS	 disorders	 in	
canine	patients	(Cuddon	and	Smith-Maxie,	1984).	
An	 anti-astrocyte	 autoantibody	 was	 recently	
identified	 in	 the	cerebrospinal	 fluid	of	dogs	with	
GME	 or	 NME,	 indicating	 a	 possible	 relationship	
between	these	two	diseases	and	the	autoantibody	
(Matsuki	et al.,	2004).	Clinical	signs	secondary	to	
MUO	may	 be	 acute	 or	 chronic	 and	 can	 result	 in	
focal	or	multifocal	lesions.	In	recent	studies,	Pugs,	
Maltese	and	Chihuahuas	were	considered	to	have	
a	 possible	 genetic	 predisposition	 for	 developing	
MUO	(Schrauwen	et al.,	2014;	Barber	et al.,	2012).	
GME	may	have	a	mild	to	moderate	CSF	lymphocytic	
pleocytosis	 (Bailey	 and	 Higgins,	 1986b).	 Other	
study	 described	 the	 cytological	 aspects	 of	
pleocytosis	 associated	 with	 GME,	 in	 which	 the	
predominant	 cells	 are	 mononuclear,	 including	
small	 lymphocytes	 (60%	 to	 90%),	 monocytes	
(10%	 to	 20%)	 and	 large	 macrophages	 (Braund,	
2005).	Neutrophils	usually	are	1%	to	20%	of	the	
cell	 population;	 but	 occasionally	 they	 can	be	 the	
predominant	 cell	 type,	 accounting	 from	 up	 to	
50%-60%	of	the	cell	type	(Braund,	2005;	Munana	
and	 Luttgen,	 1988;	 Bailey	 and	 Higgins,	 1986a).	
According	to	Braund	(2005)	in	dogs	with	GME,	the	
total	nucleated	cell	count	usually	ranges	from	50	
to	 900	 cell/μL,	 varying	 from	0	 to	 11,840	 cell/μl.	
Thomas	and	Eger	(1989)	showed	that	about	10%	
of	dogs	with	GME	had	normal	cell	count	values.	
In	 another	 study	 (Lamb	 et al.,	 2005)	
the	 authors	 described	 the	 signs	 that	 may	 be	
associated	with	meningoencephalitis	on	magnetic	
resonance	 imaging	 (MRI).	 Twenty-five	 dogs	
with	 inflammatory	 CSF	 were	 included,	 76%	 of	
them	 showing	 MRI	 abnormalities.	 Although	 as	
shown	above,	several	diagnostic	techniques	were	
employed	 for	 the	 diagnosis	 of	 MUO	 a	 definitive	
diagnosis	 can	only	be	made	by	histopathological	
examination	(Uchida	et al.,	2016).
In	 order	 to	 reach	 a	 diagnosis,	 the	 infectious	
diseases	 of	 the	 CNS	 should	 be	 commonly	 ruled	
out	 by	 serum/CSF	 titers	 and	 polymerase	 chain	
reaction	 testing,	 although	 studies	 demonstrated	
that	 infectious	 etiologies	 are	 uncommon	 causes	
of	 inflammatory	 disease	 in	 the	 USA	 and	 Europe	
(Schatzberg	et al.,2005;	Barber	et al.,	2012).	MRI	
and	 CSF	 analysis	 are	 also	 important	 diagnostic	
tools	 and	 could	 be	 considered	 for	 the	 definitive	
diagnosis	(Smith	et al.,	2009).
Degenerative and neoplastic disorders on 
canine CSF
In	 CNS	 neoplastic	 disorders	 CSF	 analysis	
is	 frequently	 nonspecific,	 but	 occasionally,	 if	
neoplastic	 cells	 are	 exfoliated	 as	 may	 occur	
in	 lymphoma,	 CSF	 analysis	 could	 confirm	 the	
diagnosis	 (Meinkoth	and	Crystal,	 1999;	Freeman	
and	 Raskin,	 2001;	 Baker	 and	 Lumsden,	 2000).	
More	 frequently,	 CSF	 analysis	 may	 help	 to	
distinguish	 the	 inflammatory	 or	 neoplastic	
nature	of	a	mass	seen	on	MRI	(Bohn	et al.,	2006).	
In	 canine	 primary	 intracranial	 neoplasia,	 CSF	
inflammatory	 changes	 can	 be	 consistent	 with	
albumino-cytological	 dissociation	 (Bagley	 et al.,	
1999).	Elevated	nucleated	cell	 counts	are	caused	
not	 only	 by	 primary	 CNS	 inflammation,	 but	 also	
in	 secondary	 inflammatory	 responses	 to	 trauma,	
neoplasia,	 infarction,	 haemorrhage	 related	 with	
intervertebral	 disc	 disease	 (IVDD)	 and	 fibro-
cartilaginous	embolism	(total	nucleated	cell	count	
6-1200	 cells/μL)	 (Meinkoth	 and	 Crystal,	 1999;	
Bagley	and	Bohn,	2003;	Lamb	et al.,	2005).	It	has	
been	recommended	that	CSF	analysis	is	avoidable	
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in	 those	 cases	 in	which	MRI	 findings	 is	 strongly	
suggesting	of	 IVDD	 (Bohn	et al.,	 2006),	 although	
CSF	 pleocytosis	 is	 positively	 associated	with	 the	
severity	of	the	spinal	cord	injury	in	IVDD.	Moreover,	
the	percentage	of	macrophages	can	be	used	as	a	
prognosticating	value	for	dogs	with	IVDD	and	loss	
of	deep	pain	sensation	(Srugo	et al.,	2011).	
Conclusion
Central	 nervous	 system	 inflammation	 is	 an	
important	disorder	to	be	considered	when	a	dog	
is	presented	with	a	history	of	abnormal	behaviour,	
vestibular	 signs	 or	 seizures.	 Cerebrospinal	 fluid	
analysis	 is	 an	 ancillary	 diagnostic	 test	 that	 can	
give	 important	 information	 about	 the	 types	 of	
CNS	 inflammation	 and	 provide	 a	 differential	
diagnosis.	Additional	diagnostic	tests	as	advanced	
clinical	 imaging	 and	 molecular	 biology	 can	
further	 corroborate	 the	 information	 obtained	 by	
CSF	 analysis	 and	 provide	 more	 accurate	 clinical	
diagnosis.	 Despite	 its	 clinical	 usefulness,	 the	
information	 obtained	 by	 cerebrospinal	 fluid	
analysis	 should	 be	 interpreted	 as	 a	 preliminary	
diagnostic.	 Furthermore,	 new	 biomarkers	 which	
can	improve	the	clinical	diagnosis	of	neurological	
diseases	need	to	be	introduced	and	tested	also	in	
veterinary	medicine.
Acknowledgments. This	 research	 did	 not	
receive	any	specific	grant	from	funding	agencies	in	
the	public,	commercial,	or	not-for-profit	sectors.
References
1.	 Aroch	I,	Baneth	G,	Salant	H,	Nachum-Biala	Y,	Berkowitz	A,	
Shamir	M,	Chai	O	(2018).	Neospora	caninum	and	Erlichia	
canis	co-infection	in	a	dog	with	meningoencephalitis.	Vet	
ClinPathol,	47:289-293.
2.	 Averill	 DR,	 De	 Lahunta	 A	 (1971).	 Toxoplasmosis	 of	 the	
canine	 nervous	 system:	 Clinicopathological	 findings	 in	
four	 cases.	 Journal	 of	 the	 American	 Veterinary	 Medical	
Association,	159:1134-1141.	
3.	 Bagley	RS,	Bohn	AA	(2003).	Interpreting	the	results	of	CSF	
analysis	 in	 dogs	 and	 cats.	 Veterinary	Medicine,	 98:499–
506.
4.	 Bagley	 RS,	 Gavin	 PR,	 Moore	 MP	 (1999).	 Clinical	 signs	
associated	with	 brain	 tumors	 in	 dogs:	 97	 cases	 (1992–
1997).	J	Am	Vet	Med	Assoc,	215:818–819.
5.	 Bailey	 C,	 Higgins	 R	 (1986a).	 Characteristic	 of	 cisternal	
cerebrospinal	fluid	associated	with	primary	brain	tumors	
in	the	dog:	A	retrospective	study.	JAVMA,188(4):414–417.
6.	 Bailey	 CS,	 Higgins	 RJ	 (1986b).	 Characteristic	 of	
cerebrospinal	fluid	associated	with	canine	granulomatous	
meningoencephalomyelitis:	 A	 retrospective	 study.	
JAVMA,188:418–42.	
7.	 Baker	 R,	 Lumsden	 JH	 (2000).	 Cerebrospinal	 fluid.	 In	 R.	
Baker,	&	 J.H.	Lumsden	 	(Eds.),	Color	Atlas	of	Cytology	of	
the	Dog	and	Cat	(pp.	95-115).	St.	Louis,	MO:	The	CV	Mosby	
Co.
8.	 Barber	 RM,	 Porter	 BF,	 Li	 Q,	 May	 M,	 Claiborne	 MK,	
Allison	 AB	 (2012).	 Broadly	 reactive	 polymerase	 chain	
reaction	for	pathogen	detection	in	canine	granulomatous	
meningoencephalomyelitis	 and	 necrotizing	
meningoencephalitis.	 Journal	 of	 Veterinary	 Internal	
Medicine,	26:962–968.	
9.	 Bohn	AA,	Wills	TB,	West	CL	 (2006).	Cerebrospinal	 fluid	
analysis	and	magnetic	resonance	imaging	in	the	diagnosis	
of	neurologic	disease	 in	dogs:	A	 retrospective	study.	Vet	
ClinPathol,	35:315–320.
10.	Braund	 K	 (2005).	 Granulomatous	 meningo-
encephalomyelitis	In	C.	Vite	(Eds.),	Clinical	Neurology	in	
Small	 Animals	 Localization,	 Diagnosis	 and	 Treatment.	
Ithaca,	NY:	International	Veterinary	Information	Service.
11.	Braund	 KG,	 Blagburn	 BL,	 Toivio-Kinnucan	 M,	 Amling	
KA,	 Pidgeon	 GL	 (1988).	 Toxoplasma	 polymyositis/
polyneuropathy	 –	 a	 new	 clinical	 variant	 in	 two	mature	
dogs.	Journal	of	the	American	Animal	Hospital	Association,	
24(1):	93-97.
12.	Chrisman	CL	(1992).	Cerebrospinal	fluid	analysis.	VetClin	
North	Am	Small	AnimPract,22:	781–810.	
13.	Christopher	 MM,	 Perman	 V,	 Hardy	 RM	 (1988).	
Reassessment	of	cytologic	values	in	canine	cerebrospinal	
fluid	 by	 use	 of	 cytocentrifugation.	 J	 Am	 Vet	Med	 Assoc,	
192:	1726.
14.	Cornelis	 I,	 Van	 Ham	 L,	 Gielen	 I,	 De	 Decker	 S,	 Bhatti	
SFM	 (2019).	 Clinical	 presentation,	 diagnotis	 findings,	
prognostic	 factors,	 treatment	and	outcome	 in	dogs	with	
meningoencephalomyelitis	of	unknown	origin:	A	review.	
The	veterinary	Journal,	244:	37-44.
15.	Cuddon	PA,	Smith-Maxie	L	(1984).	Reticulosis	of	the	central	
nervous	 system	 in	 the	 dog.	 CompendContinEducPract	
Vet,6:	23–32.
16.	Davidson	MG	(2000).	Toxoplasmosis.	Veterinary	Clinics	of	
North	America	Small	Animal	Practice,	30(5):	1051-1062.
17.	De	 Lahunta	 A	 (1977).	 Cerebrospinal	 fluid	 and	
hydrocephalus	 In	Veterinary	Neuroanatomy	 and	Clinical	
Neurology	(pp.	33).	Philadelphia:	WB	Saunders.	
18.	Di	Terlizzi	R,	Platt	SR	(2009).	The	function,	composition	
and	analysis	of	cerebrospinal	fluid	in	companion	animals:	
Part	II	–	Analysis.	Vet	J.	180(1):	15-32.
19.	Dubey	 JP,	 Lappin	 MR	 (2012).	 Toxoplasmosis	 and	
Neosporosis.	 InC.E.	 Greene	 (Eds.)	 Infectious	 Diseases	
of	 the	 Dog	 and	 Cat.	 4th	 ed.	 (pp.	 806-827).	 Saint	 Louis:	
Elsevier.
20.	Freeman	 KP,	 Raskin	 RE	 (2001)	 Cytology	 of	 the	 central	
nervous	system.	In	R.E.	Raskin,	&	D.J.	Meyer	(Eds.),	Atlas	of	
Canine	and	Feline	Cytology	(pp:	325–365).	Philadelphia,	
PA:	WB	Saunders.
21.	Greene	 CE,	 Appel	 MJ	 (2006).	 Canine	 distemper.	 In	 C.E.	
Greene	 (Eds.),	 Infectious	 diseases	 of	 the	 dog	 and	 cat	
(pp.25-41).	St	Louis:	Elsevier.
22.	Jamison	 EM,	 Lumsden,	 JH	 (1988).	 Cerebrospinal	 fluid	
analysis	 in	 the	 dog:	 methodology	 and	 interpretation.	
DANCIU et al
109
Bulletin UASVM Veterinary Medicine 76 (2) / 2019
In	 Seminars	 in	 veterinary	medicine	 and	 surgery	 (small	
animal),	3:2,	122.
23.	Lamb	 CR,	 Croson	 PJ,	 Capello	 R,	 Cherubini	 GB	 (2005).	
Magnetic	resonance	findings	in	25	dogs	with	inflammatory	
cerebrospinal	 fluid.	 Veterinary	 Radiology	 &	 Ultrasound,	
46	(1):	17-22.
24.	Matsuki	 N,	 Fujiwara	 K,	 Tamahara	 S	 (2004).	 Prevalence	
of	autoantibodies	in	cerebrospinal	fluids	from	dogs	with	
various	CNS	diseases.	J	Vet	Med	Sci,	66:	295–297.
25.	Meinkoth	 JH,	 Crystal	 MA	 (1999).	 Cerebrospinal	 fluid	
analysis.	In	R.L.	Cowell,	R.D.	Tyler,	&	J.	H.	Meinkoth	(Eds.),	
Diagnostic	Cytology	and	Hematology	of	the	Dog	and	Cat.	
(2nded.)	pp.	125–141).	St.	Louis,	MO:	Mosby.
26.	Munana	 KR,	 Luttgen	 PJ	 (1988).	 Prognostic	 factors	 for	
dogs	with	granulomatous	meningoencephalomyelitis:	42	
cases	(1982–1996).	JAVMA,	212:	1902–1906.
27.	Nelson	 RW,	 Couto	 CG	 (2014).	 Small	 animal	 internal	
medicine.	(5thed.).	St.	Louis:	Elsevier,	(Chapter	66).
28.	Nesbit	 JW,	 Lourens	 DC,	 Williams	 MC	 (1981).	 Spastic	
paresis	 in	 two	 littermate	 pups	 caused	 by	 Toxoplasma	
gondii.	Journal	of	the	South	African	Veterinary	Association,	
52:	243-246.
29.	O’Brien	 CR,	 Krockenberger	 MB,	 Wigney	 DI,	 Martin	 P,	
Malik	R	(2004).	Retrospective	study	of	feline	and	canine	
cryptococcosis	in	Australia	from	1981	to	2001:195	cases.	
Medical	Mycology,	42:	449-460.
30.	Paixão	 TA,	 Santos	 RL	 (2004).	 Encefalite	 por	 Neospora	
caninum	e	Toxoplasma	gondi	iem	cães.	ClínicaVeterinária,	
9(48):	44-52.	
31.	Radaelli	 ST,	 Platt	 SR	 (2002).	 	 Bacterial	 Meningo-
encephalomyelitis	 in	 Dogs:	 A	 Retrospective	 Study	 of	 23	
Cases	(1990-1999).	J	Vet	Intern	Med,	16:	159-163.
32.	Schatzberg	 SJ,	 Haley	 NJ,	 Barr	 SC,	 De	 Lahunta	 A,	 Sharp	
NJ	 (2005)	 Polymerase	 chain	 reaction	 screening	
for	 DNA	 viruses	 in	 paraffin-embedded	 brains	
from	 dogs	 with	 necrotizing	 meningoencephalitis,	
necrotizing	 leukoencephalitis,	 and	 granulomatous	
meningoencephalitis.	 Journal	 of	 Veterinary	 Internal	
Medicine	19:	553–559.	
33.	Schrauwen	 I,	 Barber	 RM,	 Schatzberg	 SJ,	 	 Siniard	
AL,	 Corneveaux	 JJ,	 Porter	 BF,	 Vernau	 KM,	 Keesler	
RI,	Matiasek	 K,	 Flegel	 T,	Miller	 AD,	 Southard	 T,	Mariani	
CL,	Johnson	GC,	Huentelman	MJ	(2014).		Identification	of	
novel	 genetic	 risk	 loci	 in	maltese	 dogs	with	 necrotizing	
meningoencephalitis	 and	 evidence	 of	 a	 shared	 genetic	
risk	across	toy	dog	breeds.	PLoS	One,	9:11.	Doi:	10.1371/
journal.pone.0112755.
34.	Smith	 PM,	 Stalin	 CE,	 Shaw	 D,	 Granger	 N,	 Jeffery	 ND	
(2009).	Comparison	of	two	regimens	for	the	treatment	of	
meningoencephalomyelitis	of	unknown	etiology.	 Journal	
of	Veterinary	Internal	Medicine,	23:	520–526.	
35.	Sorjonen	 DC	 (1990).	 Clinical	 and	 histopathological	
features	of	granulomatous	meningoencephalomyelitis	 in	
dogs.	JAAHA,	26:	141–147.
36.	Srugo	 I,	 Aroch	 I,	 Christopher	 MM,	 Chai	 O,	 Goralnik	 L,	
Bdolah-Abram	 T,	 Shamir	 MH	 (2011).	 Association	 of	
Cerebrospinal	Fluid	Analysis	Findings	with	Clinical	Signs	
and	 Outcome	 in	 Acute	 Nonambulatory	 Thoracolumbar	
Disc	Disease	in	Dogs,	J	Vet	Med,	25:	846–855.
37.	Suter	 MM,	 Hauser	 B,	 Palmer	 DG,	 Oettli	 P	 (1984).	
Polymyositis	 –	 polyradiculitis	 due	 to	 toxoplasmosis	 in	
the	 dog:	 Serology	 and	 tissue	 biopsy	 as	 diagnostic	 aids.	
ZentralblattfuerVeterinaermedizin,	31(10):	792-	798.	
38.	Talarico	 LR,	 Schatzberg	 SJ	 (2010).	 Idiopathic	
granulomatous	 and	 necrotising	 inflammatory	 disorders	
of	the	canine	central	nervous	system:	a	review	and	future	
perspectives.	J.	Small	AnimPract,	51:	138–149.
39.	Thomas	 JB,	 Eger	 C	 (1989).	 Granulomatous	
meningoencephalomyelitis	 in	 21	 dogs,	 Journal	 of	 Small	
Animal	Practice,	30	(5):	287-293.
40.	Thomas	WB,	(1998).	Inflammatory	diseases	of	the	central	
nervous	 system	 in	 dogs.	 Clinical	 Techniques	 in	 Small	
Animal	Practice,	13(3):167-178.
41.	Tipold	 A	 (1995).	 Diagnosis	 of	 inflammatory	 and	
infectious	diseases	of	the	central	nervous	system	in	dogs:	
a	retrospective	study.	J	Vet	Int	Med,	9:	304-314.
42.	Uchida	 K,	 Park	 E,	 Tsuboi	M,	 Chambers	 JK,	 Nakayama	H	
(2016).	Pathological	and	immunological	features	of	canine	
necrotizing	 meningoencephalitis	 and	 granulomatous	
meningoencephalitis.	Vet	J,	213:	72–77.
43.	Vandevelde	 M,	 Spano	 JS	 (1977).	 Cerebrospinal	 fluid	
cytology	 in	 canine	neurologic	disease.	Am	 J	Vet	Res,	38:	
1827-1832.
44.	William	BT	(1998).	Inflammatory	Diseases	of	the	central	
nervous	 system	 in	 dogs.	 Clinical	 Techniques	 in	 Small	
Animal	Practice,	13(3):	167-168.
Clinical	Relevance	of	Cerebrospinal	Fluid	in	Dogs	(Review)
